ABSTRACT
INTRODUCTION

Cisplatin,
Cisdiaminedichloroplatinum (CDDP), is an effective chemotherapeutic agent against multiple human cancers, including ovarian and head and neck malignancies [1] .
Although the therapeutic effects of cisplatin are improved by dose escalation, high-dose therapy is limited by its cumulative nephrotoxicity [2] . Reports of accidental overdose leading to renal failure indicate that cisplatin is sufficiently potent to be toxic to human [3] . The mechanism of cisplatin-induced nephrotoxicity is not fully understood, but inflammation and oxidative stress have been reported in cisplatininduced nephrotoxicity [4, 5] . Hannemann and Baumann [6] , reported that CDDP induced a high production of the lipid peroxidation product malondialdehyde (MDA), indirectly confirming a relationship between lipid peroxidation and platinum compound-induced nephrotoxicity. Ajith, et al.
[5] , reported that upon CDDP administration, reduced glutathione (GSH) content and catalase (CAT) activity are decreased.
Cytokines, particularly tumor necrosis factor-α (TNF-α), appear to contribute to cisplatin-induced renal injury and to coordinate the activation of a large network of chemokines and cytokines in the kidney following cisplatin injection ] ٧ ] . So, inhibition of TNF-α production or its activity reduces cisplatin-induced renal dysfunction and structural damage [8] . A number of anti-inflammatory and antioxidant agents, such as curcumin, vitamin C, and vitamin E, provide protective effects against cisplatininduced nephrotoxicity [5, 9] . Although N-Acetyl cysteine (NAC) a thiolcontaining antioxidant, has been documented to be effective in attenuating renal injury induced by CDDP, the precise mechanisms involved in its renoprotection have not been completely clarified [10] .
Aim of the work
The present study was conducted to evaluate the protective effect of NAC on cisplatin-induced nephrotoxicity by evaluating renal functions, oxidant/antioxidant status of the kidney tissues (in the form of catalase, MDA, reduced glutathione levels), renal and systemic TNF-α and renal histopathology in albino rats.
MATERIALS & METHODS
Animals
A total of 40 male albino rats weighing 200 ± 25 g were included in the current study and divided into four groups each of ١0 rats. . Group IV treated with intraperitoneal injection of NAC (250 mg/kg) once daily, at the second day, rats of that group were injected by a single bolus of cisplatin, 5m/kg, i.v., i.e. saline and NAC were given daily for one week, while CDDP was given as one single bolus dose. After five days from cisplatin injections, rats were sacrificed by decapitation and blood samples were collected into clean tubes and allowed to stand at room temperature then centrifuged at 5000 rpm for 10 minutes to get the clear serum, kidneys were also separated from all groups for biochemical and histopathological analysis.
The The concentration of MDA as a marker of lipid peroxidation (LPO) was determined according to the method described by Buege and Aust [12] , which is based on the reaction with thiobarbituric acid, and was expressed as nmol/ g tissue.
GSH level was measured in renal cortex homogenate using colorimetric assay kit (Biodiagnostic, Egypt) according to the manufacturer's instruction. The method is based on the reduction of 5, 5′-dithiobis (2-nitrobenzoic acid) with reduced glutathione to produce a yellow colored compound. The values were expressed as mmol/g tissue [13] .
Measurement of TNF-α level:
The level of TNF-α in serum and renal cortical homogenate was determined by using enzyme-linked immunosorbent assay (ELISA) kit. (KOMA BIOTECH INC. KOREA) according to the manufacturer's instructions. A standard curve was constructed from standards provided by the manufacturer.
Histopathological examination:
One kidney of each rat was fixed in 10% formalin solution and then dehydrated in ascending grades of alcohol and embedded in paraffin. Sections at 4 μm-thickness were taken, stained with hematoxylin-eosin and evaluated by light microscope. The pathologist was blinded to treatment and evaluated the kidney sections at random for the presence or absence of lesion.
Statistical analysis
All data are presented as mean+ SD. Significant difference among data were determined using one-way ANOVA and independent Student's t test with SPSS version 10. P < 0.05 denoted the presence of statistically significant difference
RESULTS
Biochemical assay:
Renal function of rats treated by saline and NAC were normal as evidenced by normal serum urea and creatinine ( (table 2) . Administration of NAC also inhibited the CDDP-induced increase in the MDA level (table 2) . TNF-α level: CDDP evoked a considerable increase in TNF-α abundance in the kidney and serum. Treating the rats with NAC significantly lessened the increment comparing with saline (control) and NAC groups ( Fig.1-2) . 
Renal histopathological examination:
Histopathological analysis of kidneys of CDDP-treated rats showed various grades of tubular necrosis as well as apoptotic bodies (Fig 4 A &  B) , compared with kidneys of group I and II (Fig.3) , a finding that denotes irreversible kidney damage. The interstitium showed inflammatory cellular infiltrate (Fig 4 C) and the cells of the renal tubules exhibited hydropic degeneration and many of their lumenae contained hyaline casts and epithelial debris (Fig.4: A, B , C and D). Treatment with NAC dramatically improved the CDDP nephrotoxicity and this was evidenced as mild histopathological changes that could be detected in the form of interstitial nephritis and mild hydropic degeneration, the later represents reversible cell injury (Fig.5) . [10] , who reported that NAC not only abolished but also significantly reversed the GSH decrease induced by CDDP. The decreased concentration of GSH increases the sensitivity of organs to oxidative and chemical injury [38] . Studies with a number of xenobiotics often produced GSH depletion [39] . The depletion of GSH also seems to be a prime factor that permits lipid peroxidation in cisplatintreated group and subsequent toxicity [16] . Treatment with NAC rendered protection due to increase in GSH concentration could protect the renal cells from oxidant's attack.
DISCUSSION
Appenroth et al., 1993
[40] , reported that N-acetylcystein, a sulfhydryl compound donor that acts by replenishing glutathione, was shown to "completely abolish the nephrotoxic effects of CDDP".
In the current study, CAT activity is significantly decreased in cisplatintreated rats, a similar result was also found by Maliakel, et al. [38] . A study done by Colbay, et al.
[41] , on nephrotoxic effect of contrast media, suggested that the decrease in antioxidant enzyme activities (catalyse) in kidney tissues was due to over usage or consumption of that enzyme due to increased oxidative stress. The decreased activity of CAT in cisplatin-treated rats, in turn may increase the lipid peroxidation [16] . Thus, the level of MDA, as a result of lipid peroxidation, increased in CDDP-treated animals. This result also coincides with that of Malaiakel, et al. [38] . Hannemann and Baumann [6] , reported that a high production of lipid peroxidation product MDA, indirectly confirming the relationship between lipid peroxidation and platinum compound-induced nephrotoxicity.
Pretreatment with NAC prevented lipid peroxidation (decreased MDA) by enhancing the renal CAT activity. Luo et al., [10] [45] , reported that CDDP stimulates systemic TNF-α and Ramesh et al. [46] , reported that CDDP stimulates TNF-α secreted by kidney epithelial cells. Ramesh and Reeves [7] , have shown that cisplatin nephrotoxicity is characterized by the activation of pro-inflammatory cytokines and chemokines, and that TNF-α plays a central role in the activation of these cytokines. Pretreatment with NAC in the current study reduced overproduction of systemic and renal TNF-α. There is a paucity of literatures concerning the effect of NAC on both systemic and renal TNF-α, but Luo et al.
[10] , reported that NAC inhibited TNF-α mRNA. Inhibition of TNF-α is capable of attenuating CDDP-induced renal injury [7] , this also explains renoprotective effect of NAC.
Conclusion and recommendations:
It could be concluded that the antioxidant NAC preserve GSH level, arrange cellular immunity, prevent lipid peroxidation, keep catalase activity, inhibit both renal and systemic TNF-α and protect renal tissues from CDDP toxicity, hence show protective effects against nephrotoxic agents. So, it might be used for protection from CDDP nephrotoxicity after modification of its dose to fit human use as the dose used in the present study was big. 
